---
title: "C.Q. Pharmaceutical Holding Co., Ltd. (000950.SZ)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/000950.SZ.md"
symbol: "000950.SZ"
name: "C.Q. Pharmaceutical Holding Co., Ltd."
industry: "Health Care Distributors"
datetime: "2026-05-20T07:11:57.078Z"
locales:
  - [en](https://longbridge.com/en/quote/000950.SZ.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/000950.SZ.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/000950.SZ.md)
---

# C.Q. Pharmaceutical Holding Co., Ltd. (000950.SZ)

## Company Overview

C.Q. Pharmaceutical Holding Co., Ltd. engages in the wholesale and retail of medicines and medical devices. The company is involved in the pharmaceutical commerce, warehousing logistics, pharmaceutical industry, and research and development businesses.

| Item | Detail |
|------|--------|
| Industry | Health Care Distributors |
| Exchange | CN Market |
| Website | [www.cq-p.com.cn](https://www.cq-p.com.cn) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:11.000Z

**Overall: C (0.55)**

**Industry**: Health Care Distributors

| Metric | Value |
|--------|-------|
| Industry Ranking | 10 / 23 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Mid - The company has stable operation of a large-cap stock and the high return of a small-cap stock.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 0.88% |  |
| Net Profit YoY | 41.58% |  |
| P/B Ratio | 0.96 |  |
| Dividend Ratio | 0.92% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 11287806252.26 |  |
| Revenue | 82413979402.75 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 3.73% | C |
| Profit Margin | 0.53% | C |
| Gross Margin | 6.85% | E |
| Revenue YoY | 0.88% | C |
| Net Profit YoY | 41.58% | B |
| Total Assets YoY | 0.43% | C |
| Net Assets YoY | 0.44% | C |
| Cash Flow Margin | -91.85% | E |
| OCF YoY | 0.88% | C |
| Turnover | 1.20 | A |
| Gearing Ratio | 75.66% | E |

```chart-data:radar
{
  "title": "Longbridge Financial Score - C.Q. Pharmaceutical Holding Co., Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "0.88%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "41.58%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "0.96",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.92%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "11287806252.26",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "82413979402.75",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "3.73%",
          "rating": "C"
        },
        {
          "name": "Profit Margin",
          "value": "0.53%",
          "rating": "C"
        },
        {
          "name": "Gross Margin",
          "value": "6.85%",
          "rating": "E"
        },
        {
          "name": "Revenue YoY",
          "value": "0.88%",
          "rating": "C"
        },
        {
          "name": "Net Profit YoY",
          "value": "41.58%",
          "rating": "B"
        },
        {
          "name": "Total Assets YoY",
          "value": "0.43%",
          "rating": "C"
        },
        {
          "name": "Net Assets YoY",
          "value": "0.44%",
          "rating": "C"
        },
        {
          "name": "Cash Flow Margin",
          "value": "-91.85%",
          "rating": "E"
        },
        {
          "name": "OCF YoY",
          "value": "0.88%",
          "rating": "C"
        },
        {
          "name": "Turnover",
          "value": "1.20",
          "rating": "A"
        },
        {
          "name": "Gearing Ratio",
          "value": "75.66%",
          "rating": "E"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 26.07 | 13/23 | 29.10 | 27.73 | 25.92 |
| PB | 0.96 | 10/23 | 0.90 | 0.81 | 0.78 |
| PS (TTM) | 0.14 | 3/23 | 0.13 | 0.11 | 0.11 |
| Dividend Yield | 0.92% | 16/23 | 1.15% | 1.06% | 0.84% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | HUADONG MEDICINE (000963.SZ) | B | C | A | B | C | B |
| 02 | SINOPHARM(CNCM LTD) (600511.SH) | C | C | A | C | C | B |
| 03 | TIBET PHARMA (600211.SH) | A | C | C | B | C | B |
| 04 | Shanghai Pharma (601607.SH) | C | C | A | D | C | C |
| 05 | GYBYS (600332.SH) | C | C | A | C | C | C |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/000950.SZ/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/000950.SZ/norm.md)
- [Related News](https://longbridge.com/en/quote/000950.SZ/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/000950.SZ/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**